# Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy

> **NCT02460107** · EARLY_PHASE1 · TERMINATED · sponsor: **Catholic University of Korea Saint Paul's Hospital** · enrollment: 9 (actual)

## Conditions studied

- Neuralgia

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT02460107
- **Lead sponsor:** Catholic University of Korea Saint Paul's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2016-11-30
- **Final completion:** 2016-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Enrolling failure (lack of participants)
- **Last updated:** 2017-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02460107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02460107, "Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02460107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*